Atlas Trials

A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.

Clinical trial NCT00381212 · COMPLETED

Trial details

NCT number
NCT00381212
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV SeropositivityAcquired Immunodeficiency Syndrome
Start date
2006-09-01
Primary completion
2008-02-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.